Exact Sciences Corp (EXAS.OQ)
86.24USD
6 Dec 2019
$2.63 (+3.15%)
$83.61
$84.02
$86.77
$84.02
595,061
610,646
$123.94
$53.09
Latest Key Developments (Source: Significant Developments)
Genomic Health Stockholders Approve Proposed Acquisition By Exact Sciences
Nov 7 (Reuters) - Genomic Health: :GENOMIC HEALTH STOCKHOLDERS APPROVE PROPOSED ACQUISITION BY EXACT SCIENCES.CO AND EXACT SCIENCES EXPECT TO CLOSE TRANSACTION ON FRIDAY, NOVEMBER 8. Full Article
Exact Sciences Posts Q3 Loss Per Share Of $0.31
Oct 29 (Reuters) - Exact Sciences Corp
Exact Sciences Sees FY 2019 Revenue Of $800 Million To $810 Million
July 29 (Reuters) - Exact Sciences Corp
Exact Sciences Q1 Loss Per Share $0.66
April 30 (Reuters) - Exact Sciences Corp
Jana Partners Dissolves Share Stake In Alphabet, Facebook; Cuts In Microsoft, GM
Nov 14 (Reuters) - :JANA PARTNERS LLC DISSOLVES SHARE STAKE OF CLASS A CAPITAL STOCK IN ALPHABET INC - SEC FILING.JANA PARTNERS LLC DISSOLVES SHARE STAKE IN FACEBOOK INC.JANA PARTNERS LLC CUTS SOLE SHARE STAKE IN MICROSOFT CORP BY 55.0 PERCENT TO 334,359 SHARES.JANA PARTNERS LLC CUTS SOLE SHARE STAKE IN GENERAL MOTORS CO BY 56 PERCENT TO 280,560 SHARES.JANA PARTNERS LLC CUTS SOLE SHARE STAKE IN ALIBABA GROUP HOLDING LTD BY 20.8 PERCENT TO 348,055 SPONSORED ADS.JANA PARTNERS LLC TAKES SOLE SHARE STAKE OF 65,000 SHARES IN UNITED STATES STEEL CORP.JANA PARTNERS LLC TAKES SOLE SHARE STAKE OF 4.6 MILLION SHARES IN FALCON MINERALS CORP.JANA PARTNERS LLC TAKES SOLE SHARE STAKE OF 1.2 MILLION SHARES IN EXACT SCIENCES CORP.JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN AUTOMATIC DATA PROCESSING INC.JANA PARTNERS LLC CUTS SOLE SHARE STAKE IN AGILENT TECHNOLOGIES INC BY 33.6 PERCENT TO 810,314 SHARES.JANA PARTNERS LLC: CHANGE IN HOLDINGS ARE AS OF SEPTEMBER 30, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF JUNE 30, 2018. Full Article
Cologuard Revenue Increased 63 Percent To $118 Million In Q3
Oct 30 (Reuters) - Exact Sciences Corp
Exact Sciences Strengthens Pipeline Capabilities With Acquisition Of Biomatrica
Oct 18 (Reuters) - Exact Sciences Corp
Exact Sciences Says Enter Agreement Through 2021 With Pfizer To Co-Promote Cologuard
Aug 22 (Reuters) - Exact Sciences Corp
Exact Sciences reports Q1 Loss Per Share of $0.33
April 26 (Reuters) - Exact Sciences Corp
Exact Sciences Q4 Loss Per Share $0.18
Feb 22 (Reuters) - Exact Sciences Corp
Alexion Pharma rejects Elliott's push for 'proactive sale'
Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously rejected hedge fund Elliott Management's push for a "proactive sale" process of the entire company because it would not be in the best interest of shareholders.